Abstract：In order to explore the enabling mechanism, as well as the mechanism of government classification regulation on smart platforms and pharmaceutical enterprises' CSR strategies, a tripartite evolutionary game model for the government, smart platforms, and pharmaceutical enterprise is constructed. Through the analysis of the critical condition, stability and evolution path of the evolution of the tripartite strategy, it reveals the action mechanism of each factor and the evolution law of the tripartite game, and analyzes the influence of key factors such as the equilibrium state of system evolution and regulatory policies based on Anylogic simulation. The research shows that: Government classification regulations significantly affect the CSR performance decision and intelligent supply chain construction of pharmaceutical enterprises and intelligent platform, and the regulatory effect is affected by the sensitivity of the policies of both parties; Increased intelligence can strengthen the risk flexibility and autonomy of intelligent platform and pharmaceutical enterprises, but there are limitations in the space and time for pharmaceutical enterprises to implement strategies; When the reward coefficient is moderate, the evolution speed of smart platforms and pharmaceutical enterprise is significantly positively correlated with the reward coefficient. Based on this, it proposes measures to improve the efficiency of government CSR governance and solve the dilemma of CSR implementation in the pharmaceutical industry.
李春发, 刘焕星, 胡培培. 政府分类规制、智能平台赋能与药企CSR策略演化[J]. 复杂系统与复杂性科学, 2022, 19(2): 17-30.
LI Chunfa, LIU Huanxing, HU Peipei. Government Classification Regulation, Intelligent Platform Empowerment and CSR Strategy Evolution of Pharmaceutical Enterprise. Complex Systems and Complexity Science, 2022, 19(2): 17-30.
[1] 阳镇,尹西明,陈劲. 新冠肺炎疫情背景下平台企业社会责任治理创新[J]. 管理学报,2020,17(10): 1423-1432. YANG Z, YIN X M, CHEN J. Platform corporate social responsibility governance innovation in the context of COVID-19 pandemic[J]. Chinese Journal of Management, 2020, 17(10): 1423-1432. [2] IRFAN R, FAIZAN A. Impact of corporate social responsibility on financial performance evidence from pharmaceutical sector listed companies of Pakistan[J]. European Business & Management, 2017, 4(1): 1-8. [3] 胡颖廉,慕玲. 超越监管看安全:国家药品安全治理体系构建[J]. 中国行政管理,2017(6): 115-120. HU Y L, MU L. Beyond the regulation: national drug safety governance system in China[J]. Chinese Public Administration, 2017(6): 115-120. [4] 陈永法,覃红艺. 我国公众参与食品和药品安全治理的不足及对策[J]. 中国药房,2016,27(16): 2164-2167. CHEN Y F, QIN H Y. Problems and countermeasures of public participation in food and drug safety administration in China[J]. China Pharmacy, 2016, 27(16): 2164-2167. [5] 方俊. 药品安全协同治理的多主体责任落实——基于我国十大典型药害事件的案例分析[J]. 理论探索,2020(1): 92-97. FANG J. The implementation of multi-principal responsibility in the coordinated management of drug safety—the case analysis based on ten typical drug damage events in China[J]. Theoretical Exploration, 2020(1): 92-97. [6] 康益敏,朱先奇,李雪莲. 企业社会责任对医药企业创新绩效影响的实证研究-动态能力的中介作用[J]. 科技进步与对策,2020,37(11): 109-116. TANG Y M, ZHU X Q, LI X L. Empirical study on the impact of corporate social responsibility to innovation performance of medical enterprises-a mediating role of dynamic capability[J]. Science & Technology Progress and Policy, 2020, 37(11): 109-116. [7] 吴方,严伟,邢潇倩. 医药企业社会责任与财务绩效相关性的实证研究——基于68家医药上市公司的面板数据[J]. 生态经济,2015,31(8): 112-116. WU F, YAN W, XING X Q. An empirical research on the impact of corporate social responsibility on corporate financial performance of pharmaceutical companies[J]. Ecological Economy, 2015, 31(8): 112-116. [8] 李春发,来茜茜. 政府监管下WEEE处理企业的社会责任履行决策研究[J]. 软科学,2020,34(8): 57-64,108. LI C F, LAI X X. The decision-making of WEEE disposer's corporate social responsibility fulfillment under government regulation[J]. Soft Science, 2020, 34(8): 57-64,108. [9] IHUGBA B U. The governance of corporate social responsibility: developing an inclusive regulation framework[J]. International Journal of Law and Management, 2014, 56(2): 105-120. [10] LIU Y, QUAN B, YANG J. Decision analysis and coordination of two-stage supply chain considering cost information asymmetry of corporate social responsibility[J]. Journal of Cleaner Production, 2019, 228: 1073-1087. [11] LI Y. Research on supply chain CSR management based on differential game[J]. Journal of Cleaner Production, 2020, 268: 122171. [12] 颜波,刘巳. 基于连续时间动态博弈的供应链企业社会责任研究[J]. 管理学报,2016,13(6): 913-921. YAN B, LIU S. Research on corporate social responsibility of supply chain based on dynamic game in continuous time[J]. Chinese Journal of Management, 2016, 13(6): 913-921. [13] 李征仁,王砚羽,石文华. 亡羊补牢:负面记录对企业社会责任的影响及绩效分析[J]. 管理评论,2020,32(9): 239-250. LI Z R, WANG Y Y, SHI W H. Better late than never: the impact of negative records on corporate social responsibility and performance analysis[J]. Management Review, 2020, 32(9): 239-250. [14] WAN X, QIE X. Poverty alleviation ecosystem evolutionary game on smart supply chain platform under the government financial platform incentive mechanism[J]. Journal of Computational and Applied Mathematics, 2019, 372: 112595. [15] MA P, WANG H, SHANG J. Supply chain channel strategies with quality and marketing effort-dependent demand[J]. International Journal of Production Economics, 2013, 144(2): 572-581. [16] 张思雪,林汉川. 创新、社会责任与产品海外形象——来自世界新兴市场的经验证据[J]. 科研管理,2018,39(12): 69-77. ZHANG S X, LIN H C. Innovation, social responsibility and overseas image of productions-an empirical study of the emerging markets in the world[J]. Science Research Management, 2018, 39(12): 69-77. [17] REINHARD S. A note on evolutionarily stable strategies in asymmetric animal conflicts[J]. Journal of Theoretical Biology, 1980, 84(1): 93-101. [18] RITZBERGER K, WEIBULL J W. Evolutionary selection in normal-form games[J]. Econometrica: Journal of the Econometric Society, 1995,63(6): 1371-1399. [19] ELLISON G, FUDENBERG D, IMHOF L A. Fast convergence in evolutionary models: a lyapunov approach[J]. Journal of Economic Theory, 2016, 161: 1-36. [20] ZOLFAGHARIAN M, ROMME A, WALRAVE B. Why, when, and how to combine system dynamics with other methods: towards an evidence-based framework[J]. Journal of Simulation, 2018, 12(2): 98-114.
